New Rules, Different Risk: The Changing Freedom to Operate Analysis for Biotechnology

Download Full Text PDF

Volume 11, Online Edition (Jun 2012)

Patent protection has evolved since the inception of the Federal Circuit in 1982. Mandated to unify the fractured application of the patent laws, the Federal Circuit initially set out to reinforce the protections guaranteed to patented inventions. For the first couple of decades the Federal Circuit succeeded in strengthening the patent system. Recently however there has been a definite shift in this trend with efforts by the Supreme Court, Federal Circuit, and Congress to both raise the bars to patentability and limit some of the earlier protections granted, particularly to biotechnology patents. Patents are now more likely to be invalidated under the new stricter patenting standards, and the narrower patents that will survive these new standards will have less enforcement capabilities owing to the weakening of many of the patent remedies available to patentees. Overall, these efforts will change the freedom-to-operate calculus of both patentees and putative infringers. This Article reviews these recent changes.

Dov Greenbaum, New Rules, Different Risk: The Changing Freedom to Operate Analysis for Biotechnology, 11 N.C. J.L. & Tech. On. 139 (2010), available at http://ncjolt.org/wp-content/uploads/2012/11/V11_On_Greenbaum.pdf.

The North Carolina Journal of Law & Technology has adopted the Open Access Program, a part of the Scholar’s Copyright Project created by Science Commons. Authors designate the conditions under which their articles are licensed. By downloading articles, you agree to comply with the license terms specified. Please contact NC JOLT at eic.ncjolt@gmail.com with permissions inquiries.